morpholinoethyl (8S,9R)-10-(S)-[1-(R)-hydroxyethyl]-4-(S)-methoxy-11-oxo-azatricyclo-[7.2.0.0(3,8)]undec-2-en-carboxylate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 内酰胺类
• 英文名称: morpholinoethyl (8S,9R)-10-(S)-[1-(R)-hydroxyethyl]-4-(S)-methoxy-11-oxo-azatricyclo-[7.2.0.0(3,8)]undec-2-en-carboxylate
• 英文别名: 2-morpholin-4-ylethyl (1S,5S,8aS,8bR)-1-[(1R)-1-hydroxyethyl]-5-methoxy-2-oxo-5,6,7,8,8a,8b-hexahydro-1H-azeto[1,2-b]isoindole-4-carboxylate
• 化学式: C₂₀H₃₀N₂O₆
• 分子量: 394.468
• InChiKey: MRBPGISIQNRTFZ-RUCLQGLUSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  28
• 可旋转键数：
  7
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  88.5
• 氢给体数：
  1
• 氢受体数：
  7

反应信息

• 作为产物：
  描述：

  4-(2-氯乙基)吗啉 、 sanfetrinem sodium salt 以 N,N-二甲基甲酰胺 为溶剂， 反应 0.5h， 以46%的产率得到morpholinoethyl (8S,9R)-10-(S)-[1-(R)-hydroxyethyl]-4-(S)-methoxy-11-oxo-azatricyclo-[7.2.0.0(3,8)]undec-2-en-carboxylate
  参考文献：
  名称：

  Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics

  摘要：

  本发明涉及一种具有对A类、C类和D类酶广谱活性的药物组合物，包括抗生素和化合物(I)的药效量，其中化合物(I)的化合物，以及将一种或多种化合物(I)的治疗有效量用作广谱β-内酰胺酶抑制剂，以及将这种药物组合物用于治疗由细菌引起的人类或动物感染。

  公开号：

  EP2085084A1

文献信息

• USE OF INHIBITOR OF BETA-LACTAMASES AND ITS COMBINATION WITH BETA-LACTAM ANTIBIOTICS
  申请人：Prezelj Andrej

  公开号：US20110172200A1

  公开（公告）日：2011-07-14

  The present invention relates to a pharmaceutical composition with broad-spectrum of activity against class A, class C and D enzymes comprising an antibiotic and a pharmaceutically effective amount of a compound of Formula (I), compounds of Formula (I), the use of a therapeutically effective amount of one or more compounds of Formula (I) as a broad-spectrum beta-lactamase inhibitor and the use of such a pharmaceutical composition for the treatment of an infection in humans or animals caused by bacteria.
• [EN] USE OF INHIBITOR OF BETA-LACTAMASES AND ITS COMBINATION WITH BETA-LACTAM ANTIBIOTICS<br/>[FR] UTILISATION D'UN INHIBITEUR DE BÊTA-LACTAMASES ET SA COMBINAISON AVEC DES ANTIBIOTIQUES BÊTA-LACTAMES
  申请人：LEK PHARMACEUTICALS

  公开号：WO2009095387A1

  公开（公告）日：2009-08-06

  The present invention relates to a pharmaceutical composition with broad-spectrum of activity against class A, class C and D enzymes comprising an antibiotic and a pharmaceutically effective amount of a compound of Formula (I), compounds of Formula (I), the use of a therapeutically effective amount of one or more compounds of Formula (I) as a broad-spectrum beta-lactamase inhibitor and the use of such a pharmaceutical composition for the treatment of an infection in humans or animals caused by bacteria.
• Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics
  申请人：LEK Pharmaceuticals d.d.

  公开号：EP2085084A1

  公开（公告）日：2009-08-05

  The present invention relates to A pharmaceutical composition with broad-spectrum of activity against class A, class C and D enzymes comprising an antibiotic and a pharmaceutically effective amount of a compound of formula (I) compounds of formula (I), the use of a therapeutically effective amount of one or more compounds of formula (I) as a broad-spectrum beta-lactamase inhibitor and the use of such a pharmaceutical composition for the treatment of an infection in humans or animals caused by bacteria.

  本发明涉及一种具有对A类、C类和D类酶广谱活性的药物组合物，包括抗生素和化合物(I)的药效量，其中化合物(I)的化合物，以及将一种或多种化合物(I)的治疗有效量用作广谱β-内酰胺酶抑制剂，以及将这种药物组合物用于治疗由细菌引起的人类或动物感染。